SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Home Point Capital Inc. (HMPT) .
Criteria proven by this page:
- VALUE (20/100, Fail) — analyst consensus target implies downside from the current price ($1.92, 17.4%).
- Analyst consensus target $1.92 (-17.4% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 34/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
20/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HMPT
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.27
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.58
Book Value / Share$0.00
Revenue / Share$1.83
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$1.92 (-17.4%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$-0.17 |
$130.25M |
$-24.2M |
-18.6% |
| 2019 |
$-0.23 |
$167.37M |
$-31.91M |
-19.1% |
| 2020 |
$4.37 |
$1.3B |
$607M |
46.7% |
| 2021 |
$1.19 |
$870.2M |
$166.3M |
19.1% |
| 2022 |
$-1.58 |
$255.65M |
$-221M |
-86.4% |
